Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05477212

Evaluation of Gut Permeability in Patients Affected by Obesity and NAFLD: Influence of Ketogenic Diet.

Evaluation of Gut Permeability in Patients Affected by Obesity and NAFLD: Influence of Ketogenic Diet on Diagnostic and Prognostic Markers in Liver Disease

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study is open label, with one arm only. In this study will be enrolled patients with obesity (BMI more than 30). Aim of the study is to determine the influence (if any) of a very low calorie ketogenic diet (VLCKD) on gut permeability and liver steatosis. The first objective is to examine the influence of obesity on the prevalence and severity of impaired intestinal permeability and hepatic steatosis. Intestinal permeability means the ability of the intestinal barrier to block the passage of substances potentially harmful to our body. The second objective is to evaluate whether a low-calorie and ketogenic dietary intervention, lasting 6 weeks, can change intestinal permeability and hepatic steatosis

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTKetogenic Dietall patients will receive a very low calorie ketogenic diet

Timeline

Start date
2022-04-28
Primary completion
2024-05-28
Completion
2025-05-28
First posted
2022-07-28
Last updated
2024-10-02

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05477212. Inclusion in this directory is not an endorsement.